Newsletter
Search
'Strict Supervision Needed': Pharmarack's Sheetal Sapale On India's Anti-Obesity Drug Boom
Sapale also spoke about why these particular drugs are so popular and the possible long-term challenges that can arise from taking them.
Regulation, Real Estate, Demand: What Fuelled The RIL-Adani Pact?
It makes a perfect union between two classic non-compete conglomerates, each betting on a license-controlled business in a country where demand for auto-fuels is booming, note brand and industry experts.
Expensive Debt Better Than Idling Biz, Experts Sum Up Private Credit Popularity
It has potential applications in turnaround working capital, loan buyouts, interim financing, and even litigation funding.
Derivatives Trap: Indian Retail Investors Are At The Mercy Of Techno-Giants
With individual retail traders losing a ton of money in a market dominated by large entities using algorithms, the real story is about a system stacked against small traders.
From Quality to Compounding: What Really Moves the Market
In this week's The Core Report: Weekend Edition, Prateek Agarwal MD and CEO, Motilal Oswal talks about how quality preserves value, but growth drives returns—especially in policy-linked, domestically focused, well-capitalised, resilient companies.
Vietnam’s US Trade Deal A Cautionary Tale For Indian Negotiators
Meanwhile, as China forges ahead in artificial intelligence and robotics, India is stuck with half-baked R&D schemes.
Navi Mumbai’s Airport Fee Puts Spotlight On Rising Passenger Cost Burden
Experts raised concerns over pricing fairness and accessibility, especially for cost-sensitive flyers.
Insurance Sector Won’t See The Death Of The Salesman Anytime Soon
A brick-and-mortar approach with agents and a human touch is still needed to sell trust with life insurance.
